Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NRIX), sold 2,894 shares at $11.50 ($33K) on 2025-04-30, disclosed to the SEC on 2025-04-30.
Open-market sale of $33k NRIX by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NRIX | SELL | 2026-08-03 | $382K | — | Filing → |
| NRIX | SELL | 2026-07-30 | $90K | — | Filing → |
| NRIX | SELL | 2026-07-02 | $259K | — | Filing → |